Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion type Assertion NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_head.
- NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion description "[They included upregulation in MS of orphan nuclear receptor Nurr1 (NR4A2), receptor-interacting serine/threonine kinase 2 (RIPK2), and silencer of death domains (SODD), and downregulation in MS of TNF-related apoptosis-inducing ligand (TRAIL), B-cell CLL/lymphoma 2 (BCL2), and death-associated protein 6 (DAXX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_provenance.
- NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion evidence source_evidence_literature NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_provenance.
- NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion SIO_000772 15755681 NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_provenance.
- NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion wasDerivedFrom befree-20140225 NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_provenance.
- NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_assertion wasGeneratedBy ECO_0000203 NP743860.RAJu_XvhrTPC9SADWz1UyRIc576TuXlj9Ap16sInpHyKM130_provenance.